Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 738563, 11 pages
http://dx.doi.org/10.1155/2015/738563
Research Article

Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy

1Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CCT CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 1900 La Plata, Argentina
2Departamento de Ciencias Biológicas, Instituto de Estudios Inmunológicos y Fisiopatológicos (IIFP), UNLP-CONICET, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, 1900 La Plata, Argentina
3Laboratorio de Inmunología de Enfermedades Respiratorias, Instituto de Medicina Experimental (IMEX), CONICET, Academia Nacional de Medicina, C1425AUM Buenos Aires, Argentina
4Servicio de Gastroenterología, Hospital de Niños “Sor María Ludovica”, 1900 La Plata, Argentina
5Servicio de Gastroenterología, Hospital “San Martín”, 1900 La Plata, Argentina

Received 16 April 2015; Accepted 5 July 2015

Academic Editor: Dezheng Zhao

Copyright © 2015 Natalia M. Bottasso Arias et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Abadie, L. M. Sollid, L. B. Barreiro, and B. Jabri, “Integration of genetic and immunological insights into a model of celiac disease pathogenesis,” Annual Review of Immunology, vol. 29, pp. 493–525, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Meresse, G. Malamut, and N. Cerf-Bensussan, “Celiac disease: an immunological jigsaw,” Immunity, vol. 36, no. 6, pp. 907–919, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Sollid and B. Jabri, “Triggers and drivers of autoimmunity: lessons from coeliac disease,” Nature Reviews Immunology, vol. 13, no. 4, pp. 294–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. E. Lundin, H. Scott, T. Hansen et al., “Gliadin-specific, HLA-DQ (alpha 10501, beta 10201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients,” The Journal of Experimental Medicine, vol. 178, no. 1, pp. 187–196, 1993. View at Google Scholar
  5. G. Trynka, K. A. Hunt, N. A. Bockett et al., “Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease,” Nature Genetics, vol. 43, no. 12, pp. 1193–1201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Fasano and C. Catassi, “Celiac disease,” The New England Journal of Medicine, vol. 367, no. 25, pp. 2419–2426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Kanda, H. Fujii, T. Tani et al., “Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans,” Gastroenterology, vol. 110, no. 2, pp. 339–343, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. A. L. Pelsers, Z. Namiot, W. Kisielewski et al., “Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility,” Clinical Biochemistry, vol. 36, no. 7, pp. 529–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. M. Derikx, N. J. Evennett, P. L. J. Degraeuwe et al., “Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis,” Gut, vol. 56, no. 10, pp. 1473–1475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. M. Derikx, A. C. E. Vreugdenhil, A. M. Van den Neucker et al., “A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP,” Journal of Clinical Gastroenterology, vol. 43, no. 8, pp. 727–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Storch and B. Corsico, “The emerging functions and mechanisms of mammalian fatty acid-binding proteins,” Annual Review of Nutrition, vol. 28, pp. 73–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. J. Murphy, D. R. Prows, J. R. Jefferson, and F. Schroeder, “Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism,” Biochimica et Biophysica Acta: Lipids and Lipid Metabolism, vol. 1301, no. 3, pp. 191–198, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Alpers, N. M. Bass, M. J. Engle, and K. Deschryver-Kecskemeti, “Intestinal fatty acid binding protein may favor differential apical fatty acid binding in the intestine,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1483, no. 3, pp. 352–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. R. K. Ockner, J. A. Manning, R. B. Poppenhausen, and W. K. L. Ho, “A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues,” Science, vol. 177, no. 4043, pp. 56–58, 1972. View at Publisher · View at Google Scholar · View at Scopus
  15. D. H. Alpers, A. W. Strauss, R. K. Ockner, N. M. Bass, and J. I. Gordon, “Cloning of a cDNA encoding rat intestinal fatty acid binding protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 2 I, pp. 313–317, 1984. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Storch and L. McDermott, “Structural and functional analysis of fatty acid-binding proteins,” Journal of Lipid Research, vol. 50, supplement, pp. S126–S131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Wolfrum, T. Börchers, J. C. Sacchettini, and F. Spener, “Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver,” Biochemistry, vol. 39, no. 6, pp. 1469–1474, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. W. S. Lagakos, X. Guan, S.-Y. Ho et al., “Liver fatty acid-binding protein binds monoacylglycerol in vitro and in mouse liver cytosol,” The Journal of Biological Chemistry, vol. 288, no. 27, pp. 19805–19815, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. V. Richieri, R. T. Ogata, and A. M. Kleinfeld, “Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB,” Journal of Biological Chemistry, vol. 269, no. 39, pp. 23918–23930, 1994. View at Google Scholar · View at Scopus
  20. K.-T. Hsu and J. Storch, “Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms,” The Journal of Biological Chemistry, vol. 271, no. 23, pp. 13317–13323, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Levy, D. Ménard, E. Delvin et al., “Localization, function and regulation of the two intestinal fatty acid-binding protein types,” Histochemistry and Cell Biology, vol. 132, no. 3, pp. 351–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. A. L. Pelsers, W. T. Hermens, and J. F. C. Glatz, “Fatty acid-binding proteins as plasma markers of tissue injury,” Clinica Chimica Acta, vol. 352, no. 1-2, pp. 15–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Not, F. Ziberna, S. Vatta et al., “Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet,” Gut, vol. 60, no. 11, pp. 1487–1493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. C. Vreugdenhil, V. M. Wolters, M. P. Adriaanse et al., “Additional value of serum I-FABP levels for evaluating celiac disease activity in children,” Scandinavian Journal of Gastroenterology, vol. 46, no. 12, pp. 1435–1441, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. M. Adriaanse, G. J. Tack, V. L. Passos et al., “Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies,” Alimentary Pharmacology and Therapeutics, vol. 37, no. 4, pp. 482–490, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Makowski, J. B. Boord, K. Maeda et al., “Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis,” Nature Medicine, vol. 7, no. 6, pp. 699–705, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Makowski and G. S. Hotamisligil, “Fatty acid binding proteins—the evolutionary crossroads of inflammatory and metabolic responses,” Journal of Nutrition, vol. 134, pp. 2464S–2468S, 2004. View at Google Scholar
  28. M. Kipp, T. Clarner, S. Gingele et al., “Brain lipid binding protein (FABP7) as modulator of astrocyte function,” Physiological Research, vol. 60, supplement 1, pp. S49–S60, 2011. View at Google Scholar · View at Scopus
  29. D. A. Sweetser, E. H. Birkenmeier, I. J. Klisak et al., “The human and rodent intestinal fatty acid binding protein genes: a comparative analysis of their structure, expression, and linkage relationships,” The Journal of Biological Chemistry, vol. 262, no. 33, pp. 16060–16071, 1987. View at Google Scholar · View at Scopus
  30. L. Chan, C.-F. Wei, W.-H. Li et al., “Human liver fatty acid binding protein cDNA and amino acid sequence. Functional and evolutionary implications,” The Journal of Biological Chemistry, vol. 260, no. 5, pp. 2629–2632, 1985. View at Google Scholar · View at Scopus
  31. B. Corsico, D. P. Cistola, C. Frieden, and J. Storch, “The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 21, pp. 12174–12178, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. I. M. Rosenberg, Protein Analysis and Purification, Birkhäuser, Boston, Mass, USA, 2005.
  33. S. Robine, C. Huet, R. Moll et al., “Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells?” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 24, pp. 8488–8492, 1985. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Abrams, B. Diamond, H. Rotterdam, and P. H. R. Green, “Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy,” Digestive Diseases and Sciences, vol. 49, no. 4, pp. 546–550, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Barada, R. H. Habib, A. Malli et al., “Prediction of celiac disease at endoscopy,” Endoscopy, vol. 46, no. 2, pp. 110–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Rostom, J. A. Murray, and M. F. Kagnoff, “American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease,” Gastroenterology, vol. 131, no. 6, pp. 1981–2002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. B. M. Mohamed, C. Feighery, C. Coates et al., “The absence of a mucosal lesion on standard histological examination does not exclude diagnosis of celiac disease,” Digestive Diseases and Sciences, vol. 53, no. 1, pp. 52–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. I. Bjarnason, D. Maxton, A. P. Reynolds, S. Catt, T. J. Peters, and I. S. Menzies, “Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 29, no. 7, pp. 630–639, 1994. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Cox, K. O. Lewis, and B. T. Cooper, “Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease,” Digestive Diseases and Sciences, vol. 44, no. 2, pp. 402–406, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Di Sabatino, M. V. Lenti, and G. R. Corazza, “Malabsorption and malabsorption tests: do they still matter?” Digestive and Liver Disease, vol. 46, no. 5, pp. 389–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Bondar, R. E. Araya, L. Guzman, E. C. Rua, N. Chopita, and F. G. Chirdo, “Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease,” PLoS ONE, vol. 9, no. 2, Article ID e89068, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Marafini, A. Di Sabatino, F. Zorzi et al., “Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies,” Alimentary Pharmacology and Therapeutics, vol. 40, no. 8, pp. 974–981, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Gajda and J. Storch, “Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 93, pp. 9–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. K. W. Reisinger, M. Elst, J. P. M. Derikx et al., “Intestinal fatty acid-binding protein: a possible marker for gut maturation,” Pediatric Research, vol. 76, no. 3, pp. 261–268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Wiercinska-Drapalo, J. Jaroszewicz, E. Siwak, J. Pogorzelska, and D. Prokopowicz, “Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis,” Regulatory Peptides, vol. 147, no. 1–3, pp. 25–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. E. Gregory, A. B. Winston, H. S. Yamamoto et al., “Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis,” Journal of Pediatrics, vol. 164, no. 6, pp. 1486–1488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. B. B. Madison, L. Dunbar, X. T. Qiao, K. Braunstein, E. Braunstein, and D. L. Gumucio, “cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine,” The Journal of Biological Chemistry, vol. 277, no. 36, pp. 33275–33283, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Yamamoto, E. Noiri, Y. Ono et al., “Renal L-type fatty acid—binding protein in acute ischemic injury,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2894–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. P. Simula, R. Cannizzaro, V. Canzonieri et al., “PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage,” Molecular Medicine, vol. 16, no. 5-6, pp. 199–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Ahmadian, J. M. Suh, N. Hah et al., “PPARγ signaling and metabolism: the good, the bad and the future,” Nature Medicine, vol. 19, no. 5, pp. 557–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. S. K. Mohapatra, A. J. Guri, M. Climent et al., “Immunoregulatory actions of epithelial cell PPAR γ at the colonic mucosa of mice with experimental inflammatory bowel disease,” PLoS ONE, vol. 5, no. 4, Article ID e10215, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Wolfrum, C. M. Borrmann, T. Börchers, and F. Spener, “Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2323–2328, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. A. M. Gajda, Y. X. Zhou, L. B. Agellon et al., “Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding,” The Journal of Biological Chemistry, vol. 288, no. 42, pp. 30330–30344, 2013. View at Publisher · View at Google Scholar · View at Scopus